Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in Amebiasis
NCT00366236Phase 3Completed
- Sponsor
- Romark Laboratories
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in amebiasis, sponsored by Romark Laboratories. Started Feb 2004; status: completed.
02
Drugs
nitazoxanide
03
Conditions
amebiasis
Beyond the preview
Go deeper on NCT00366236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366236.